Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Phare Bio — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Phare Bio Awarded Up To $27 Million from ARPA-H for AI-Powered Drug Discovery and Developing New Antibiotics

Sep 26, 2024•over 1 year ago

Contract Type

agreement

BostonBiotechnology

Description

Phare Bio, along with MIT's Collins Lab and Harvard's Wyss Institute, has been awarded up to $27 million in funding from ARPA-H to enhance their generative AI discovery platform and produce novel classes of antibiotics.

Company Information

Company

Phare Bio

Location

Boston, Massachusetts, United States

About

Phare Bio is a company using AI to discover and develop new antibiotics in collaboration with MIT and Harvard's Wyss Institute.

Predictive Intelligence
Strategic

ML-powered predictions for Phare Bio's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months